News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Helix Biopharma (CC:HBP) Signs Agreement With Apotex Inc.



10/19/2005 5:12:52 PM

AURORA, ONTARIO--(CCNMatthews - Feb. 28, 2005) - Helix BioPharma is pleased to announce that its wholly-owned subsidiary, PharmaDerm Laboratories, has entered into an agreement with Apotex, the largest Canadian-owned pharmaceutical company, to identify and characterize a lead formulation for Apotex's burgeoning topical therapeutic product line.

Read at CCNMatthews


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES